Suppr超能文献

老年人高血压:阿替洛尔与硝苯地平联合应用的研究

Hypertension in the elderly: a study of a combination of atenolol and nifedipine.

作者信息

Duckett G K, Cheadle B

机构信息

St Thomas' Hospital, Stockport, Manchester.

出版信息

Br J Clin Pract. 1990 Feb;44(2):52-4.

PMID:2200490
Abstract

The antihypertensive effects and tolerability of a once-daily, fixed combination of atenolol 50 mg and nifedipine retard 20 mg ('Nif-Ten') were monitored in a 12-month open study in 30 elderly hypertensive patients, whose blood pressure was inadequately controlled after four weeks treatment with atenolol 50 mg once daily. Sitting (and standing) blood pressure and heart rate one to four hours after dosing were recorded at entry (191/95 mmHg) and at the end of the run-in period (186/93 mmHg). After one month's therapy with the fixed combination the mean sitting blood pressure fell to 169/89 mm Hg and was maintained at this level for the entire 12-month period of observation. During the study four patients complained of side effects on fixed combination therapy with one patient withdrawn due to flushes and hot sweats. One other patient suffered flushes and hot sweats and two patients complained of mild dizziness. There were no demonstrable effects of fixed combination therapy upon the biochemical parameters measured. We conclude that the fixed combination of atenolol plus nifedipine retard was well tolerated over a 12-month period in the group of elderly hypertensive patients studied. The combination appears to exert a greater antihypertensive effect than the beta-blocker monotherapy with no evidence of tachyphylaxis, although these findings require confirmation in a controlled trial.

摘要

在一项针对30例老年高血压患者的为期12个月的开放性研究中,监测了每日一次服用50mg阿替洛尔和20mg缓释硝苯地平(“硝苯地平-阿替洛尔”)的固定复方制剂的降压效果和耐受性。这些患者每日一次服用50mg阿替洛尔治疗四周后血压控制不佳。在入组时(191/95mmHg)和导入期结束时(186/93mmHg)记录给药后1至4小时的坐位(及站位)血压和心率。使用该固定复方制剂治疗一个月后,平均坐位血压降至169/89mmHg,并在整个12个月的观察期内维持在该水平。在研究期间,有4例患者抱怨固定复方制剂治疗有副作用,其中1例因潮热和多汗而退出。另有1例患者出现潮热和多汗,2例患者抱怨有轻度头晕。固定复方制剂治疗对所测生化指标无明显影响。我们得出结论,在本研究的老年高血压患者组中,阿替洛尔加缓释硝苯地平的固定复方制剂在12个月期间耐受性良好。该复方制剂似乎比β受体阻滞剂单药治疗具有更强的降压作用,且无快速耐受性的证据,尽管这些发现需要在对照试验中得到证实。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验